News
-
-
-
COMMUNIQUÉ DE PRESSE
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
Kowa Company Ltd. to present non-clinical data for novel antibody drug-loaded unimicelle conjugate K-679 at AACR Annual Meeting 2026 showcasing tumor-selective pharmacokinetics